| Registry | NCT01576900 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 124 (Actual) |
| Sponsor | Seoul National University Hospital (Other); collaborators: Ferring Pharmaceuticals |
| Conditions | Nocturia |
| Interventions | SyBeMeP (Systemized Behavioural Modification education Program) (Behavioral) |
| Dates | start 2012-04-01, primary completion 2014-10-01, completion 2014-10-01, first posted 2012-04-13, last updated 2014-11-20 |
| Locations | 1 site in South Korea |
Related Papers Related Patents Related Grants Related Experts
All trials for Nocturia All trials of SyBeMeP (Systemized Behavioural Modification education Program)
In patients with nocturia, combinational treatment of DDAVP and SyBeMeP might show better outcomes.
Systemic video instruction might prove to be beneficial by helping patients have better understanding on treatment and replacing healthcare personnel.
One of main reason of nocturia is known as nocturnal polyuria. For the treatment of nocturia caused by overactive bladder, the combined therapy of anticholinergics plus behavioural modification has been established as the first line therapy. However, nocturia mainly comes from polyuria has been treated with desmopressin pharmacotherapy and the effect of behaviour modification education has not yet evaluated. Therefore, in this study, short term synergistic effect of combinational treatment of desmopressin and SyBeMeP (Systemized Behavioral Modification education Program) comparing desmopressin monotherpy will be evaluated in patients with nocturia.
Control group: Desmopressin (Minirin Tablet 0.1-0.4mg/day) + simple instruction Study group: Desmopressin (Minirin Tablet 0.1-0.4mg/day) + SyBeMeP. Patients will be randomized and assigned to each group at the ratio of 1:1. At screening visit, flowmetry and residual urine measurement, Complete Blood Count (CBC), atypical diabetes mellitus (ADM), electrolytes, urinalysis micro, urine concentration, and demographic examination will be done. Voiding diary will be distributed. At 2nd visit, patients will be randomized and each treatment will be initiated. IPSS, ICIQ-nocturia, and PPTB will be completed. Voiding diary will be distributed. At 3rd visit (2 weeks after from 2nd visit): IPSS, ICIQ-nocturia, and PPTB will be completed. Assess the treatment outcome including voiding diary analysis.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Desmopressin monotherapy | Control group: Desmopressin (Minirin Tablet 0.1-0.4mg/day) + simple instruction | ||
| Combination group | Behavioral: SyBeMeP (Systemized Behavioural Modification education Program) | Study group: Desmopressin (Minirin Tablet 0.1-0.4mg/day) + SyBeMeP * Patients will be randomized and assigned to each group at the ratio of 1:1. |
Sex: All, ages: 20 Years to 80 Years
Inclusion Criteria: * A patient with nocturia, who visited department of urology as outpatient * Have not been treated with desmopressin for at least 6 months before Exclusion Criteria: * Sleep disorder, * history of medication for voiding, * diabetes insipidus, * diabetes mellitus, * cardiovascular disease, * voiding difficulties (including residual urine of more than 100ml), * small bladder capacity, * overactive bladder, * illiteracy, * psychiatric disorder and having no intention to be enrolled by written agreement
| Facility | City | Country | Status |
|---|---|---|---|
| Seoul National University Hospital | Seoul, Seoul | South Korea |